메뉴 건너뛰기




Volumn 17, Issue 6, 1996, Pages 929-935

An incremental response to high-dose therapy in multiple myeloma

Author keywords

Multiple myeloma; Stem cell support; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PARAPROTEIN; VINCRISTINE;

EID: 8944232098     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (34)
  • 1
    • 0028775544 scopus 로고
    • The treatment of multiple myeloma
    • Alexanian R, Dimopoulos M. The treatment of multiple myeloma. New Engl J Med 1994; 330: 484-489.
    • (1994) New Engl J Med , vol.330 , pp. 484-489
    • Alexanian, R.1    Dimopoulos, M.2
  • 2
    • 0026585927 scopus 로고
    • Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: An overview of published trials
    • Gregory WM, Richards MA, Malpas JS. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol 1992; 10: 334-342.
    • (1992) J Clin Oncol , vol.10 , pp. 334-342
    • Gregory, W.M.1    Richards, M.A.2    Malpas, J.S.3
  • 3
    • 0026070258 scopus 로고
    • Allogeneic bone marrow transplantation in multiple myeloma
    • Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma. New Engl J Med 1991; 325: 1267-1273.
    • (1991) New Engl J Med , vol.325 , pp. 1267-1273
    • Gahrton, G.1    Tura, S.2    Ljungman, P.3
  • 4
    • 0027057481 scopus 로고
    • Phase I study of busulphan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma
    • Bensinger WI, Buckner CD, Clift RA et al. Phase I study of busulphan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 1992; 10: 1492-497.
    • (1992) J Clin Oncol , vol.10 , pp. 1492-1497
    • Bensinger, W.I.1    Buckner, C.D.2    Clift, R.A.3
  • 5
    • 0020578180 scopus 로고
    • High-dose intravenous melphalan for plasma-cell leukaemia and myeloma
    • McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; 2: 822-824.
    • (1983) Lancet , vol.2 , pp. 822-824
    • McElwain, T.J.1    Powles, R.L.2
  • 6
    • 85047693579 scopus 로고
    • Multiple myeloma treated with high dose intravenous melphalan
    • Selby P, McElwain TJ, Nandi AC et al. Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 1987; 66: 55-62.
    • (1987) Br J Haematol , vol.66 , pp. 55-62
    • Selby, P.1    McElwain, T.J.2    Nandi, A.C.3
  • 7
    • 0022510876 scopus 로고
    • High dose melphalan with autologous bone marrow transplantation for multiple myeloma
    • Barlogie B, Hall R, Zander A et al. High dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
    • (1986) Blood , vol.67 , pp. 1298-1301
    • Barlogie, B.1    Hall, R.2    Zander, A.3
  • 8
    • 0024350166 scopus 로고
    • Intensive treatment of multiple myeloma and criteria for complete remission
    • Gore ME, Selby PJ, Viner C et al. Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 1989; 2: 879-82.
    • (1989) Lancet , vol.2 , pp. 879-882
    • Gore, M.E.1    Selby, P.J.2    Viner, C.3
  • 9
    • 0025203141 scopus 로고
    • Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors
    • Jagannath S, Barlogie B, Dicke K et al. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
    • (1990) Blood , vol.76 , pp. 1860-1866
    • Jagannath, S.1    Barlogie, B.2    Dicke, K.3
  • 10
    • 0026570466 scopus 로고
    • Intensive combined therapy for previously untreated aggressive myeloma
    • Attal M, Huguet F, Schlaifer D et al. Intensive combined therapy for previously untreated aggressive myeloma. Blood 1992; 79: 1130-1136.
    • (1992) Blood , vol.79 , pp. 1130-1136
    • Attal, M.1    Huguet, F.2    Schlaifer, D.3
  • 11
    • 0026729417 scopus 로고
    • Double-intensive therapy in high-risk multiple myeloma
    • Harousseau JL, Milpied N, Laporte JP et al. Double-intensive therapy in high-risk multiple myeloma. Blood 1992; 79: 2827-2833.
    • (1992) Blood , vol.79 , pp. 2827-2833
    • Harousseau, J.L.1    Milpied, N.2    Laporte, J.P.3
  • 12
    • 0027367897 scopus 로고
    • High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients
    • Fermand JP, Chevret S, Ravaud P et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
    • (1993) Blood , vol.82 , pp. 2005-2009
    • Fermand, J.P.1    Chevret, S.2    Ravaud, P.3
  • 13
    • 0027027417 scopus 로고
    • A comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer
    • Rowlings PA, Rawling CM, To LB et al. A comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer. Aust NZ J Med 1992; 22: 660-664.
    • (1992) Aust NZ J Med , vol.22 , pp. 660-664
    • Rowlings, P.A.1    Rawling, C.M.2    To, L.B.3
  • 14
    • 0024495749 scopus 로고
    • The optimisation of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia
    • To LB, Haylock DN, Thorp DL et al. The optimisation of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplant 1989; 4: 41-47.
    • (1989) Bone Marrow Transplant , vol.4 , pp. 41-47
    • To, L.B.1    Haylock, D.N.2    Thorp, D.L.3
  • 15
    • 0025126768 scopus 로고
    • Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells fom the peripheral blood
    • To LB, Shepperd KM, Haylock DN et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells fom the peripheral blood. Exp Hematol 1990; 18: 442-447.
    • (1990) Exp Hematol , vol.18 , pp. 442-447
    • To, L.B.1    Shepperd, K.M.2    Haylock, D.N.3
  • 16
    • 0027025074 scopus 로고
    • Defining a therapeutic dose of peripheral blood stem cells
    • Bender JG, To LB, Williams S et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-342.
    • (1992) J Hematother , vol.1 , pp. 329-342
    • Bender, J.G.1    To, L.B.2    Williams, S.3
  • 17
    • 8944248977 scopus 로고
    • Busulphan/cyclophosphamide conditioning followed by transplantation of autologous peripheral blood progenitor cells as treatment for advanced multiple myeloma
    • Schiller G, Lieb G, Lee M et al. Busulphan/cyclophosphamide conditioning followed by transplantation of autologous peripheral blood progenitor cells as treatment for advanced multiple myeloma. Blood 1992; 80: 121a.
    • (1992) Blood , vol.80
    • Schiller, G.1    Lieb, G.2    Lee, M.3
  • 18
    • 8944226761 scopus 로고
    • Myeloablative high-dose therapy (HDT) and autologous peripheral blood mononuclear cell (PBMC) rescue for multiple myeloma (MM)
    • Abstr. 1234
    • Long GD, Chao NJ, Negrin RS, Blume KG. Myeloablative high-dose therapy (HDT) and autologous peripheral blood mononuclear cell (PBMC) rescue for multiple myeloma (MM). Proc ASCO 1993; 12: 365 (Abstr. 1234).
    • (1993) Proc ASCO , vol.12 , pp. 365
    • Long, G.D.1    Chao, N.J.2    Negrin, R.S.3    Blume, K.G.4
  • 19
    • 8944259597 scopus 로고
    • Autologous peripheral blood stem cell (PBSC) transplantation as first line treatment of multiple myeloma: Preliminary results of an Italian multicenter pilot study
    • Abstr. 1382
    • Tribalto M, Avvisati G, Papa G et al. Autologous peripheral blood stem cell (PBSC) transplantation as first line treatment of multiple myeloma: preliminary results of an Italian multicenter pilot study. Proc ASCO 1993; 12: 404 (Abstr. 1382).
    • (1993) Proc ASCO , vol.12 , pp. 404
    • Tribalto, M.1    Avvisati, G.2    Papa, G.3
  • 20
    • 0028335012 scopus 로고
    • High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
    • Gianni AM, Tarella C, Bregni M et al. High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. J Clin Oncol 1994; 12: 503-509.
    • (1994) J Clin Oncol , vol.12 , pp. 503-509
    • Gianni, A.M.1    Tarella, C.2    Bregni, M.3
  • 21
    • 0026733455 scopus 로고
    • Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
    • Jagannath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
    • (1992) Blood , vol.80 , pp. 1666-1672
    • Jagannath, S.1    Vesole, D.H.2    Glenn, L.3
  • 22
    • 0027435042 scopus 로고
    • Thiotepa, busulphan, and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma
    • Dimopoulos MA, Alexanian R, Przepiorka D et al. Thiotepa, busulphan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324-2328.
    • (1993) Blood , vol.82 , pp. 2324-2328
    • Dimopoulos, M.A.1    Alexanian, R.2    Przepiorka, D.3
  • 23
    • 0028069256 scopus 로고
    • Limited value of myeloablative therapy for late multiple myeloma
    • Alexanian R, Dimopoulos M, Smith T et al. Limited value of myeloablative therapy for late multiple myeloma. Blood 1994; 83: 512-516.
    • (1994) Blood , vol.83 , pp. 512-516
    • Alexanian, R.1    Dimopoulos, M.2    Smith, T.3
  • 24
    • 84983963471 scopus 로고
    • Blood stem cell transplants in myeloma
    • Gale RP, Juttner CA, Henon P (eds). Cambridge University Press: Cambridge
    • Barlogie B, Fermand JP, Henon P et al. Blood stem cell transplants in myeloma. In: Gale RP, Juttner CA, Henon P (eds). Blood Stem Cell Transplants. Cambridge University Press: Cambridge, 1994, pp 150-163.
    • (1994) Blood Stem Cell Transplants , pp. 150-163
    • Barlogie, B.1    Fermand, J.P.2    Henon, P.3
  • 25
    • 0027275603 scopus 로고
    • Collection of peripheral blood stem cells in multiple myeloma following high-dose cyclophosphamide with or without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
    • Boiron JM, Marit G, Faberes C et al. Collection of peripheral blood stem cells in multiple myeloma following high-dose cyclophosphamide with or without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 1993; 12: 49-55.
    • (1993) Bone Marrow Transplant , vol.12 , pp. 49-55
    • Boiron, J.M.1    Marit, G.2    Faberes, C.3
  • 26
    • 0025219465 scopus 로고
    • Recombinant human granulocyte macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma
    • Gianni AM, Bregni M, Siena S et al. Recombinant human granulocyte macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 768-778.
    • (1990) J Clin Oncol , vol.8 , pp. 768-778
    • Gianni, A.M.1    Bregni, M.2    Siena, S.3
  • 27
    • 0028029787 scopus 로고
    • Prognostic factors in autologous stem cell transplantation for multiple myeloma: An EBMT Registry Study
    • European Group for Bone Marrow Transplantation.
    • Bjorkstrand B, Goldstone AH, Ljungman P et al. Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow Transplantation. Leuk Lymphoma 1994; 15: 265-72.
    • (1994) Leuk Lymphoma , vol.15 , pp. 265-272
    • Bjorkstrand, B.1    Goldstone, A.H.2    Ljungman, P.3
  • 28
    • 0026080877 scopus 로고
    • Bone marrow transplantation in multiple myeloma
    • Barlogie B, Gahrton G. Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 1991; 7: 71-79.
    • (1991) Bone Marrow Transplant , vol.7 , pp. 71-79
    • Barlogie, B.1    Gahrton, G.2
  • 29
    • 0002856621 scopus 로고
    • Prospective randomized comparison of MACOP-B versus rhGM-CSF supported high-dose sequential myeloablative chemoradiotherapy in diffuse large cell lymphomas
    • Abstr. 951
    • Gianni AM, Bregni M, Siena S et al. Prospective randomized comparison of MACOP-B versus rhGM-CSF supported high-dose sequential myeloablative chemoradiotherapy in diffuse large cell lymphomas. Proc ASCO 1991; 10: 274 (Abstr. 951).
    • (1991) Proc ASCO , vol.10 , pp. 274
    • Gianni, A.M.1    Bregni, M.2    Siena, S.3
  • 30
    • 0028155974 scopus 로고
    • Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study
    • Ayash LJ, Elias A, Wheeler C et al. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 1994; 12: 37-44.
    • (1994) J Clin Oncol , vol.12 , pp. 37-44
    • Ayash, L.J.1    Elias, A.2    Wheeler, C.3
  • 31
    • 0028963126 scopus 로고
    • Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma
    • Bjorkstrand B, Ljungman P, Bird J et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 1995; 15: 367-371.
    • (1995) Bone Marrow Transplant , vol.15 , pp. 367-371
    • Bjorkstrand, B.1    Ljungman, P.2    Bird, J.3
  • 32
    • 0027496486 scopus 로고
    • Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma
    • Anderson KC, Andersen J, Soiffer R et al. Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568.
    • (1993) Blood , vol.82 , pp. 2568
    • Anderson, K.C.1    Andersen, J.2    Soiffer, R.3
  • 33
    • 0342361404 scopus 로고
    • A comparison of engraftment following high dose chemotherapy with autologous bone marrow transplantation with either full bone marrow or CD34+ cells isolated with the Baxter Isolex 300™
    • Abstr. 362
    • Broun ER, Traycoff C, Graves V et al. A comparison of engraftment following high dose chemotherapy with autologous bone marrow transplantation with either full bone marrow or CD34+ cells isolated with the Baxter Isolex 300™. Exp Hematol 1994; 22: 775 (Abstr. 362).
    • (1994) Exp Hematol , vol.22 , pp. 775
    • Broun, E.R.1    Traycoff, C.2    Graves, V.3
  • 34
    • 0003337838 scopus 로고
    • A randomised trial of maintainance therapy with Intron-A following high dose melphalan and ABMT in myeloma
    • Abstr. 1232
    • Cunningham D, Powles R, Malpas JS et al. A randomised trial of maintainance therapy with Intron-A following high dose melphalan and ABMT in myeloma. Proc ASCO 1993; 12: 364 (Abstr. 1232).
    • (1993) Proc ASCO , vol.12 , pp. 364
    • Cunningham, D.1    Powles, R.2    Malpas, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.